SCHEMBL24384683

SCHEMBL24384683

CCCC[C@H](CO)CCc1nc(N)nc2cccc(F)c12

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 7/20 0.50
▸ TLR8 Q9NR97 6/20 0.42
▸ TLR7 Q9NYK1 2/20 0.42
▸ HSP90AB1 P08238 1/20 0.41
▸ CSNK1A1 P48729 1/20 0.37
▸ CSNK1D P48730 1/20 0.37
▸ PRKCD Q05655 1/20 0.37
▸ PAK1 Q13153 1/20 0.37
▸ CAMK2B Q13554 1/20 0.37
▸ CAMK2G Q13555 1/20 0.37
▸ CAMK2D Q13557 1/20 0.37
▸ TAOK1 Q7L7X3 1/20 0.37
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22825595 0.87 KCNH2 (0.55) KCNH2TLR8TLR7CSNK1A1CSNK1D
SCHEMBL21325597 0.87 KCNH2 (0.43) KCNH2TLR8TLR7HSP90AB1CSNK1A1
SCHEMBL24384583 0.86 KCNH2 (0.44) KCNH2TLR8TLR7CSNK1A1CSNK1D
SCHEMBL22825820 0.85 KCNH2 (0.44) KCNH2TLR8TLR7HSP90AB1CYP2D6
SCHEMBL22825828 0.84 KCNH2 (0.41) KCNH2TLR8TLR7
SCHEMBL22825984 0.83 KCNH2 (0.41) KCNH2TLR8TLR7CSNK1A1CSNK1D
SCHEMBL21325636 0.81 CYP2C9 (0.58) KCNH2TLR8TLR7CSNK1A1CSNK1D
SCHEMBL24384690 0.81 KCNH2 (0.52) KCNH2TLR8TLR7HSP90AB1CYP2D6
SCHEMBL24384556 0.81 KCNH2 (0.39) KCNH2TLR8TLR7CYP2D6
SCHEMBL22825458 0.81 KCNH2 (0.52) KCNH2TLR8TLR7HSP90AB1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3759083-B1 2,4-DIAMINOQUINAZOLINE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF VIRUS INFECTIONS, CANCER OR ALLERGIES JANSSEN SCIENCES IRELAND UNLIMITED CO (IE) 2022-05-04 — — EP disclosed
Send feedback